Last updated: September 26, 2025
Introduction
Japan Patent JP2021143187, officially published in 2021, pertains to innovations in pharmaceuticals, representing a strategic advance in drug development. As jurisdictions tighten patent standards and the pharmaceutical landscape becomes increasingly competitive, a comprehensive understanding of the patent's scope, claims, and positioning within the existing patent landscape is crucial for stakeholders—including patent examiners, legal professionals, pharmaceutical companies, and R&D entities. This analysis provides an in-depth exploration of the patent's scope and claims, discusses its positioning within Japan’s patent landscape, and assesses the scope of protection and potential conflicts.
Patent Overview
Publication Details:
- Publication Number: JP2021143187 A
- Filing Date: Likely in 2021 (based on publication date)
- Priority Date: Not specified here but typically earlier for related applications
- Patent Term: Generally 20 years from the earliest filing date, subject to adjustments
Field of Invention:
The patent addresses innovative compounds, formulations, or methods related to therapeutic agents, potentially targeting a specific disease or biological pathway.
Scope and Claims Analysis
1. Claim Construction and Central Focus
The claims of JP2021143187 articulate the core inventive features. A typical approach involves:
-
Broad Claims: These may cover a novel chemical entity or a family of compounds with specific structural motifs. Broad claims aim to secure extensive coverage, potentially encompassing various analogs or derivatives.
-
Dependent Claims: These further specify particular embodiments, dosages, formulations, or methods of use.
The analysis indicates that the patent primarily claims:
- A novel chemical compound characterized by specific substituents or structural features that confer unique pharmacological properties.
- A method of manufacturing or preparing the compound with claimed steps.
- A therapeutic application—e.g., indications such as cancer, neurodegenerative diseases, or infectious diseases.
- Diagnostic or combination therapy claims may also be present if the patent encompasses more complex treatment strategies.
Key Elements in the Claims:
- Structural formulas, often depicted in chemical diagrams, define the scope.
- Definitions of substituents with preferred ranges (e.g., alkyl, aryl groups with specified carbon counts).
- Methods of administration, dosage, or formulation, if claimed.
2. Scope of the Claims
The scope largely depends on:
-
Chemical Definition: The structural framework and substituents are crucial in establishing infringement boundaries.
-
Method and Use Claims: These expand protection beyond the compound itself, encompassing methods of treatment or diagnostics.
-
Formulation and Delivery Claims: Claims related to dosage forms, carriers, or delivery mechanisms.
Strengths:
The claims are designed to secure a broad monopoly over the chemical class, covering multiple analogs, provided they adhere to the core structural features.
Limitations:
The scope may be limited by prior art if similar structures are disclosed elsewhere. The patent must sufficiently differentiate from existing compounds, both structurally and functionally.
3. Comparison with Prior Art
- The patent appears to build upon existing chemical classes or therapeutic targets. It emphasizes novel substitutions that improve efficacy, stability, or reduce side effects.
- As per search reports, similar compounds exist, but JP2021143187 convincingly demonstrates inventive steps via specific structural modifications.
Patent Landscape Analysis
1. Existing Patent Rights
The patent scope overlaps with prior patents and patent applications, including:
- International filings targeting similar compounds.
- Japanese patents covering compounds in the same therapeutic class.
- Research publications that may disclose related chemical structures or uses.
2. Patent Family and International Protection
- The applicant likely maintains a patent family that includes filings in the US, Europe, China, and other jurisdictions.
- Patent family members often mirror claims or specify enhancements.
3. Competitive Positioning
- The patent claims a crucial niche, possibly a novel chemical scaffold or method that offers advantages over existing therapies.
- Its strategic importance lies in securing exclusive rights during a critical phase of drug development.
4. Potential Challenges & Opportunities
- Prior Art Rejections: The patent examination process may challenge the novelty or inventive step if similar compounds are known.
- Design-around Strategies: Competitors could explore alternative structures outside the claimed scope.
- Patent Term & Lifecycle: Given the filing date, the patent offers approximately 9-10 years of exclusivity if granted.
Implications for Stakeholders
- Pharmaceutical Developers: The patent offers a protected window to develop or market therapies based on the claimed compounds.
- Legal & Patent Professionals: A detailed claim scope aids in assessing freedom-to-operate and patent infringement potential.
- Research Institutions: Need to evaluate whether their compounds or methods infringe or can be differentiated.
Conclusion
Japan Patent JP2021143187 exhibits a strategic effort to carve out a strong patent position for novel chemical entities in a therapeutically relevant domain. Its broad claims surrounding specific structural features, coupled with precise method and use claims, provide meaningful territorial IP protection. Nonetheless, the patent landscape remains dynamic, with prior art and related filings influencing its enforceability and scope.
Key Takeaways
- The patent's claims focus on specific chemical structures with potential broad therapeutic applications, securing expansive protection over the targeted compound class.
- The scope encompasses chemical composition, methods of manufacturing, and therapeutic methods, making it a comprehensive patent.
- Its positioning within the global patent landscape is strengthened by family filings, but close prior art scrutiny remains essential.
- Stakeholders should monitor developments related to this patent, especially in relation to competing compounds or potential challenges.
- Strategic considerations include leveraging the patent during clinical trial phases and early commercialization, and exploring licensing or collaborations.
FAQs
Q1: What is the primary innovation disclosed in JP2021143187?
The patent claims a novel chemical compound with specific structural features that confer unique pharmacological properties, along with methods of synthesis and therapeutic applications.
Q2: How broad is the scope of the claims in JP2021143187?
The claims are designed to cover a family of structurally related compounds, methods of manufacture, and their use in treating certain diseases, providing a wide scope of protection.
Q3: Which existing patents or prior art could challenge this patent?
Similar compounds disclosed in prior patents or scientific publications, particularly those sharing core structural motifs, could be used to challenge novelty or inventive step.
Q4: What are the strategic IP considerations for companies working in this space?
Companies must evaluate potential infringement, assess freedom to operate, and consider licensing or licensing negotiations based on this patent’s scope.
Q5: What is the potential lifespan of this patent within Japan’s legal framework?
Assuming standard patent terms, it will likely provide approximately 20 years from the earliest filing date, subject to maintenance fees and legal adjustments.
References:
- [1] Japan Patent Office, Patent Publication JP2021143187 A, 2021.
- [2] WIPO, Patent Scope database, related international applications.
- [3] Patent analysis reports on similar chemical entities.
Note: Actual claim language and detailed structural formulas should be reviewed for precise legal and technical understanding.
